In April of 2017, Mackenzie was diagnosed with Amyloidosis, a rare and deadly bone marrow disorder. Amyloidosis affects each person differently, but commonly affects vital organs such as the heart, kidneys, liver, spleen, nervous system, and digestive tract. Severe amyloidosis can result in life-threatening damage to these organs or even failure. The “typical” amyloidosis patient is a 50 to 80-year-old male with organ involvement, whereas Mackenzie was a 23-year-old female with no organ involvement whatsoever, making her case extremely unique. She has since successfully undergone chemotherapy and an autologous stem cell transplant at the Mayo Clinic in Rochester, MN. In Mackenzie’s case, a significant advantage to her successful outcome was her early diagnosis. As a result, Mackenzie’s Mission was created in order to (1) raise money to support Amyloidosis research at leading institutions such as the Mayo Clinic, Boston University, Tufts University and Scripps Research, as well as (2) increase awareness for early diagnosis through the Amyloidosis Speakers Bureau (ASB). The ASB educates medical students and residents across the U.S. via patient speakers and clinical videos. The entirety of every donation will be used to support the development of early detection and innovative treatment methods that are so desperately needed for others to live a longer, better quality of life.